GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Ignyte Acquisition Corp (NAS:IGNY) » Definitions » Total Current Liabilities

Ignyte Acquisition (Ignyte Acquisition) Total Current Liabilities : $1.48 Mil (As of Jun. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Ignyte Acquisition Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Ignyte Acquisition's total current liabilities for the quarter that ended in Jun. 2022 was $1.48


Ignyte Acquisition Total Current Liabilities Historical Data

The historical data trend for Ignyte Acquisition's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ignyte Acquisition Total Current Liabilities Chart

Ignyte Acquisition Annual Data
Trend Dec20 Dec21
Total Current Liabilities
0.08 0.44

Ignyte Acquisition Quarterly Data
Nov20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Total Current Liabilities Get a 7-Day Free Trial 0.07 0.09 0.44 0.74 1.48

Ignyte Acquisition Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Ignyte Acquisition's Total Current Liabilities for the fiscal year that ended in Dec. 2021 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.438+0
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=0.44

Ignyte Acquisition's Total Current Liabilities for the quarter that ended in Jun. 2022 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=1.186+0.298
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=1.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Ignyte Acquisition Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Ignyte Acquisition's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Ignyte Acquisition (Ignyte Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
640 5th Avenue, 4th Floor, New York, NY, USA, 10019
Ignyte Acquisition Corp is a blank check company.
Executives
Richard J Rosenstock director C/O GAINES BERLAND INC, 1055 STEWART AVENUE, BETHPAGE NY 11714
Cheryl Cohen director C/O MEDIVATION, INC., 201 SPEAR ST., 3RD FLOOR, SAN FRANCISCO CA 94105
Charles Wilson director C/O UNUM THERAPEUTICS, 200 CAMBRIDGEPARK DR., STE. 3100, CAMBRIDGE MA 02140
Ignyte Sponsor Llc 10 percent owner 640 5TH AVENUE, 4TH FLOOR, NEW YORK NY 10019
David I. Rosenberg director, 10 percent owner, officer: Co-Chief Executive Officer C/O IGNYTE ACQUISITION CORP., 640 5TH AVENUE, 4TH FLOOR, NEW YORK NY 10019
John Andrew Boockvar director C/O IGNYTE ACQUISITION CORP., 640 5TH AVENUE, 4TH FLOOR, NEW YORK NY 10019
David J. Strupp director, 10 percent owner, officer: Co-Chief Executive Officer 107 DUNNING ROAD, NEW CANAAN CT 06840
Steven Neil Kaplan director, officer: Chief Financial Officer C/O IGNYTE ACQUISITION CORP., 640 5TH AVENUE, 4TH FLOOR, NEW YORK NY 10019
Deerfield Management Company, L.p. (series C) 10 percent owner, other: Possible Member of 10% Group 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Deerfield Mgmt L.p. 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Partners, L.p. 10 percent owner, other: Possible Member of 10% Group 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
James E Flynn 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017